Clinical Trials | December 17, 2025
Cynata completes patient enrollment for Phase 2 aGvHD clinical trial
Patient enrolment has been completed in Cynata's Phase 2 clinical trial of CYP-001 in acute graft versus host disease
Patient enrolment has been completed in Cynata's Phase 2 clinical trial of CYP-001 in acute graft versus host disease
The pharmaceutical giant now expects 2026 revenues to land between $59.5 billion and $62.5 billion
Clinical trial enrollment has long been a bottleneck in drug development
Indoco received the Establishment Inspection Report from the USFDA for its API manufacturing facility
The Phase-2b study is a randomized, double-blind, placebo-controlled trial that will enroll approximately 195 patients across 35 sites in the USA
This is the first approval of a prescription transdermal dosage Form in the European markets from this facility
The approval follows strong results from Roche’s phase II NOBILITY and phase III REGENCY studies
_256_384.jpg)
Tirzepatide is the first and only dual agonist glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
HYMPAVZI’s safety profile was generally favorable
Subscribe To Our Newsletter & Stay Updated
